Cargando…
Blocking IL-1 in systemic inflammation
A growing number of systemic inflammatory diseases characterized in part by recurrent fevers, leukocytosis, anemia, and elevated acute phase proteins are linked to interleukin (IL)-1 activity since rapid and sustained resolution is observed upon specific blockade of IL-1 receptors. Rapid resolution...
Autor principal: | Dinarello, Charles A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213199/ https://www.ncbi.nlm.nih.gov/pubmed/15867089 http://dx.doi.org/10.1084/jem.20050640 |
Ejemplares similares
-
Regulatory T cells and IL-10 in allergic inflammation
por: Hawrylowicz, Catherine M.
Publicado: (2005) -
Grand Challenge in Inflammation
por: Dinarello, Charles A.
Publicado: (2012) -
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019) -
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
por: Tengesdal, Isak W., et al.
Publicado: (2021) -
To beta block or not to beta block; that is the question
por: Ince, Can
Publicado: (2015)